D. Kim Turgeon

5.3k citations

79 papers · 3.9k indexed · 1 hit paper · h-index 32

Oncology top 2%
Molecular Biology top 10%
Pharmacology top 0.2%
Surgery top 5%
Pediatrics, Perinatology and Child Health top 2%

Co-authors: Kenneth S. Lown Dean E. Brenner Paul B. Watkins Mack T. Ruffin Alan B. Leichtman Jeffrey L. Barnett Leslie Z. Benet Robert R. Mayo
Topics: Colorectal Cancer Screening and Detection (14 papers)Esophageal Cancer Research and Treatment (11 papers)Gastric Cancer Management and Outcomes (9 papers)
Cited by: Pharmacology Transplantation Molecular Medicine
Journals: Journal of Clinical Oncology Gastroenterology PLoS ONE
Partner nations: United States Canada China

In The Last Decade

D. Kim Turgeon

75 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

1997 576 citations Kenneth S. Lown, D. Kim Turgeon et al. Clinical Pharmacology & Therapeutics profile →

Peers

Countries citing papers authored by D. Kim Turgeon

Since Specialization

Citations

This map shows the geographic impact of D. Kim Turgeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Kim Turgeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Kim Turgeon more than expected).

Fields of papers citing papers by D. Kim Turgeon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Kim Turgeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Kim Turgeon. The network helps show where D. Kim Turgeon may publish in the future.

Co-authorship network of co-authors of D. Kim Turgeon

This figure shows the co-authorship network connecting the top 25 collaborators of D. Kim Turgeon. A scholar is included among the top collaborators of D. Kim Turgeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Kim Turgeon. D. Kim Turgeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Flexible fiber cholangioscope for detection of near-infrared fluorescence 2022 ·VideoGIE ·(unknown),(unknown),(unknown),Richard S. Kwon,Erik Wamsteker,D. Kim Turgeon,Eric J. Seibel,Thomas D. Wang	4
2	A Multi-Mineral Intervention to Modulate Colonic Mucosal Protein Profile: Results from a 90-Day Trial in Human Subjects 2021 ·Nutrients ·Muhammad N. Aslam,Shannon D. McClintock,(unknown),(unknown),(unknown),Venkatesha Basrur,Ingrid L. Bergin,Suzanna M. Zick,Ananda Sen,D. Kim Turgeon,James Varani	10
3	Ulcerative Colitis-Derived Colonoid Culture: A Multi-Mineral-Approach to Improve Barrier Protein Expression 2020 ·Frontiers in Cell and Developmental Biology ·Muhammad N. Aslam,Shannon D. McClintock,Durga Attili,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Michael K. Dame,D. Kim Turgeon,James Varani	17
4	A Calcium-Rich Multimineral Intervention to Modulate Colonic Microbial Communities and Metabolomic Profiles in Humans: Results from a 90-Day Trial 2019 ·Cancer Prevention Research ·Muhammad N. Aslam,Christine M. Bassis,Ingrid L. Bergin,(unknown),Suzanna M. Zick,Ananda Sen,D. Kim Turgeon,James Varani	14
5	Increases in Colonic Bacterial Diversity after ω-3 Fatty Acid Supplementation Predict Decreased Colonic Prostaglandin E2 Concentrations in Healthy Adults 2019 ·Journal of Nutrition ·Zora Djurić,Christine M. Bassis,Melissa Plegue,Ananda Sen,D. Kim Turgeon,(unknown),Vincent B. Young,Dean E. Brenner,Mack T. Ruffin	15
6	Spatial Variation of the Native Colon Microbiota in Healthy Adults 2018 ·Cancer Prevention Research ·Kaitlin J. Flynn,Mack T. Ruffin,D. Kim Turgeon,Patrick D. Schloss	54
7	Calcium-Induced Differentiation of Human Colon Adenomas in Colonoid Culture: Calcium Alone versus Calcium with Additional Trace Elements 2018 ·Cancer Prevention Research ·Shannon D. McClintock,Justin A. Colacino,Durga Attili,Michael K. Dame,(unknown),(unknown),Venkatesha Basrur,(unknown),D. Kim Turgeon,James Varani,Muhammad N. Aslam	13
8	Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations after dietary supplementation with ω-3 fatty acids 2018 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Matthew Wilson,Ananda Sen,Dave Bridges,D. Kim Turgeon,Dean E. Brenner,William L. Smith,Mack T. Ruffin,Zora Djurić	2
9	Multimodal Video Colonoscope for Targeted Wide-Field Detection of Nonpolypoid Colorectal Neoplasia 2016 ·Gastroenterology ·Bishnu Joshi,Asha Pant,Xiyu Duan,Anoop Prabhu,Erik Wamsteker,Richard S. Kwon,Grace H. Elta,Scott R. Owens,Henry D. Appelman,Thomas D. Wang,D. Kim Turgeon	11
10	Effects of a Mediterranean Diet Intervention on Anti- and Pro-Inflammatory Eicosanoids, Epithelial Proliferation, and Nuclear Morphology in Biopsies of Normal Colon Tissue 2015 ·Nutrition and Cancer ·Zora Djurić,D. Kim Turgeon,Jianwei Ren,Andrew P. Neilson,(unknown),Ian Waters,Alexander Chan,(unknown),Mack T. Ruffin,Ananda Sen,Dean E. Brenner	10
11	Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer 2014 ·Molecular Carcinogenesis ·Suzanna M. Zick,D. Kim Turgeon,Jianwei Ren,Mack T. Ruffin,Benjamin D. Wright,Ananda Sen,Zora Djurić,Dean E. Brenner	35
12	Effects of Ginger Supplementation on Cell-Cycle Biomarkers in the Normal-Appearing Colonic Mucosa of Patients at Increased Risk for Colorectal Cancer: Results from a Pilot, Randomized, and Controlled Trial 2013 ·Cancer Prevention Research ·(unknown),Roberd M. Bostick,Thomas U. Ahearn,D. Kim Turgeon,Mack T. Ruffin,Zora Djurić,Ananda Sen,Dean E. Brenner,Suzanna M. Zick	78
13	Microsatellite Instability and DNA Mismatch Repair Protein Deficiency in Lynch Syndrome Colorectal Polyps 2012 ·Cancer Prevention Research ·Matthew B. Yurgelun,Ajay Goel,Jason L. Hornick,Ananda Sen,D. Kim Turgeon,Mack T. Ruffin,Norman E. Marcon,John A. Baron,Robert S. Bresalier,Sapna Syngal,Dean E. Brenner,C. Richard Boland,Elena M. Stoffel	83
14	Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer 2012 ·European Journal of Cancer Prevention ·Yan Jiang,D. Kim Turgeon,Benjamin D. Wright,Elkhansa Sidahmed,Mack T. Ruffin,Dean E. Brenner,Ananda Sen,Suzanna M. Zick	42
15	Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia 2011 ·Cancer Prevention Research ·Robert E. Carroll,Richard V. Benya,D. Kim Turgeon,Shaiju K. Vareed,Malloree Neuman,Luz M. Rodriguez,Madhuri Kakarala,Philip M. Carpenter,Christine E. McLaren,Frank L. Meyskens,Dean E. Brenner	403
16	Affinity Peptide for Targeted Detection of Dysplasia in Barrett's Esophagus 2010 ·Gastroenterology ·Meng Li,(unknown),Bishnu Joshi,(unknown),Cyrus Piraka,Badih Joseph Elmunzer,D. Kim Turgeon,Timothy D. Johnson,Henry D. Appelman,David G. Beer,Thomas D. Wang	70
17	Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial 2008 ·Cancer Prevention Research ·Frank L. Meyskens,Christine E. McLaren,Daniel Pelot,Sharon Fujikawa-Brooks,Philip M. Carpenter,Ernest T. Hawk,Gary J. Kelloff,Michael J. Lawson,Jayashri Kidao,John A. McCracken,Gregory Albers,Dennis J. Ahnen,D. Kim Turgeon,Steven Goldschmid,Peter Lance,Curt H. Hagedorn,Daniel L. Gillen,Eugene W. Gerner	392
18	Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members 2001 ·Endocrinology ·D. Kim Turgeon	88
19	The Caffeine Breath Test Does Not Identify Patients Susceptible to Tacrine Hepatotoxicity 1996 ·Hepatology ·Robert J. Fontana,D. Kim Turgeon,Thomas F. Woolf,Margaret J. Knapp,Norman L. Foster,Paul B. Watkins	16
20	The erythromycin breath test predicts the clearance of midazolam* 1995 ·Clinical Pharmacology & Therapeutics ·Kenneth S. Lown,Kenneth E. Thummel,Patrick E. Benedict,Danny D. Shen,D. Kim Turgeon,Stanley Berent,Paul B. Watkins	108

About D. Kim Turgeon

D. Kim Turgeon is a scholar working on Gastroenterology, Transplantation and Pharmacology, having authored 79 papers that have together received 3.9k indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (14 papers), Esophageal Cancer Research and Treatment (11 papers) and Gastric Cancer Management and Outcomes (9 papers). The work is most often cited by research in Pharmacology (895 citations), Transplantation (198 citations) and Molecular Medicine (279 citations). D. Kim Turgeon has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Kenneth S. Lown, Dean E. Brenner, Paul B. Watkins, Mack T. Ruffin, Alan B. Leichtman, Paul B. Watkins, Jeffrey L. Barnett, Leslie Z. Benet, Robert R. Mayo and Christine E. McLaren. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact